The end-stage renal disease industry and exit strategies for nephrologists

Health Care Manager

Volumn 25, Issue 4, 2006, Pages 356-361

  Sullivan, John D ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Acquisition; Dialysis; Divestiture; Valuation

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; COMMERCIAL PHENOMENA; CONTRACT; ECONOMIC ASPECT; HUMAN; NEPHROLOGY; ORGANIZATION AND MANAGEMENT; PHYSICIAN;

COMMERCE; CONTRACTS; ECONOMIC COMPETITION; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; PHYSICIANS;

EID: 33751026261     PISSN: 15255794     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126450-200610000-00012     Document Type: Review

References (8)

1. DaVita, Inc. Securities and Exchange Form 10K, 2004 Annual Report.
2. DaVita, Inc. DaVita to Acquire Gambro Healthcare, a Renal Dialysis Services Company [press release]. December 7, 2004.
3. Fresenius Medical Care. Fresenius Medical Care to Acquire Renal Care Group, Inc [press release]. May 4, 2005.
4. Fresenius Medical Care. Fresenius Medical Care Announces Changes of Corporate Credit Rating [press release]. July 1, 2005.
5. Fresenius Medical Care. Securities and Exchange Form 10K, 2004 Annual Report.
6. Renal Care Group, Securities and Exchange Form 10K, 2004 Annual Report.
7. United States Renal Data System. 2005 Annual Report.
8. United Network for Organ Sharing Data. Available at: www.unos.org/data/. Accessed 2005.